578 Shares in SPDR S&P Biotech ETF (XBI) Purchased by Covington Capital Management

Covington Capital Management bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 578 shares of the exchange traded fund’s stock, valued at approximately $41,000.

Other large investors have also recently added to or reduced their stakes in the company. Worth Venture Partners LLC raised its position in SPDR S&P Biotech ETF by 37.4% during the fourth quarter. Worth Venture Partners LLC now owns 7,994 shares of the exchange traded fund’s stock valued at $573,000 after purchasing an additional 2,178 shares in the last quarter. Towercrest Capital Management purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $628,000. OLD Mission Capital LLC raised its position in SPDR S&P Biotech ETF by 1,301.3% during the fourth quarter. OLD Mission Capital LLC now owns 60,256 shares of the exchange traded fund’s stock valued at $4,323,000 after purchasing an additional 55,956 shares in the last quarter. Candriam Luxembourg S.C.A. raised its position in SPDR S&P Biotech ETF by 13.2% during the fourth quarter. Candriam Luxembourg S.C.A. now owns 4,195 shares of the exchange traded fund’s stock valued at $301,000 after purchasing an additional 490 shares in the last quarter. Finally, MML Investors Services LLC raised its position in SPDR S&P Biotech ETF by 31.0% during the fourth quarter. MML Investors Services LLC now owns 61,171 shares of the exchange traded fund’s stock valued at $4,389,000 after purchasing an additional 14,466 shares in the last quarter.

XBI opened at $87.99 on Tuesday. SPDR S&P Biotech ETF has a 12 month low of $64.38 and a 12 month high of $101.55.

WARNING: “578 Shares in SPDR S&P Biotech ETF (XBI) Purchased by Covington Capital Management” was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.themarketsdaily.com/2019/03/26/578-shares-in-spdr-sp-biotech-etf-xbi-purchased-by-covington-capital-management.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Article: Why do companies issue convertible shares?

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.